Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Center Exploratory Study to Evaluate the Safety and Efficacy of FKC288 in Subjects With Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

NCT05978661 is registered in ClinicalTrials.gov with Nanjing University School of Medicine as lead sponsor.

NCT NCT05978661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05978661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Center Exploratory Study to Evaluate the Safety and Efficacy of FKC288 in Subjects With Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Lead sponsor
Nanjing University School of Medicine
Phase
Phase 1
Overall status
Unknown status
Start date
August 29, 2023
Completion date
June 30, 2026
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

light chain amyloidosis